...
首页> 外文期刊>Clinical and experimental pharmacology & physiology >Possible participation of chloride ion channels in ATP release from cancer cells in suspension.
【24h】

Possible participation of chloride ion channels in ATP release from cancer cells in suspension.

机译:氯离子通道可能参与悬浮液中癌细胞释放的ATP。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

1. Cancer cells must detach from the primary focus to initiate the process of metastasis. Previously, we demonstrated that intracellular Ca(2+) levels are increased in endothelial cells in the presence of cancer cells and that ATP derived from these cells causes this increase. The present study clarifies the mechanism of ATP release from cancer cells by investigating the effects of Cl(-) channel inhibitors and other drugs on ATP release from human fibrosarcoma cells (HT-1080 cells). 2. Levels of extracellular ATP and its metabolites were measured using high-performance liquid chromatography (HPLC) with fluorescent detection. 3. Significantly more extracellular ATP was released by suspended than by adherent HT-1080 cells. The Cl(-) channel inhibitors 5-nitro-2-(3-phenylpropylamino) benzoic acid (100 micromol/L), gadolinium (100 micromol/L) and niflumic acid (100 micromol/L) all significantly inhibited ATP release from HT-1080 cells (1 x 10(3) /mL) to 39.7 +/- 6.5, 28.5 +/- 2.5 and 82.5 +/- 4.1% of control, respectively. 4. Neither of the p-glycoprotein inhibitors (i.e. 50 micromol/L quinidine and 90 micromol/L verapamil) had any effect on ATP release from HT-1080 cells. The gap junction hemichannel inhibitor Gap26 (300 micromol/L) slightly, but significantly, decreased ATP release by approximately 20%. The gap junction inhibitor 18-alpha-glycyrrhetinic acid (10 micromol/L) tended to inhibit ATP release from HT-1080 cells, but the difference did not reach statistical significance. 5. These findings indicate that Cl(-) channels play the most important role in ATP release from detached cancer cells and that gap junction hemichannels are also associated with ATP release.
机译:1.癌细胞必须脱离主要焦点才能启动转移过程。以前,我们证明了在癌细胞存在的情况下内皮细胞中细胞内Ca(2+)的水平增加,并且源自这些细胞的ATP导致这种增加。本研究通过研究Cl(-)通道抑制剂和其他药物对人纤维肉瘤细胞(HT-1080细胞)ATP释放的影响,阐明了ATP从癌细胞释放的机制。 2.使用带荧光检测的高效液相色谱(HPLC)测量细胞外ATP及其代谢物的水平。 3.与粘附的HT-1080细胞相比,悬浮释放的细胞外ATP明显更多。 Cl(-)通道抑制剂5-硝基-2-(3-苯基丙基氨基)苯甲酸(100 micromol / L),g(100 micromol / L)和尼氟酸(100 micromol / L)均显着抑制HT释放ATP -1080细胞(1 x 10(3)/ mL)分别达到对照的39.7 +/- 6.5、28.5 +/- 2.5和82.5 +/- 4.1%。 4.两种p-糖蛋白抑制剂(即50微摩尔/升的奎尼丁和90微摩尔/升的维拉帕米)均不影响HT-1080细胞的ATP释放。间隙连接半通道抑制剂Gap26(300 micromol / L)略微但显着降低了ATP释放约20%。间隙连接抑制剂18-α-甘草次酸(10μmol/ L)倾向于抑制HT-1080细胞中的ATP释放,但差异没有统计学意义。 5.这些发现表明,Cl(-)通道在从分离的癌细胞释放ATP中起最重要的作用,并且间隙连接半通道也与ATP释放相关。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号